Durães, André R.
de Souza Lima Bitar, Yasmin
Filho, José Admirço L.
Schonhofen, Igor S.
Camara, Edmundo J. N.
Roever, Leonardo
Cardoso, Hugo E. D. P.
Akrami, Kevan M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study
https://doi.org/10.1007/s40256-020-00449-3
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study
https://doi.org/10.1007/s40268-018-0249-5
Article History
First Online: 6 October 2018
Compliance with Ethical Standards
:
: André R. Durães, MD, PhD, Yasmin de S. L. Bitar, Bachelor in Health, José Admirço L. Filho, MD, PhD, Igor S. Schonhofen, MD, Edmundo J. N. Camara, MD, PhD, Leonardo Roever, MD, MHS, Hugo E. D. P. Cardoso, and Kevan M. Akrami, MD have no conflicts of interest that are directly relevant to the content of this study.
: This work will be supported by the General Hospital Roberto Santos—HGRS.